Free Trial

GRAIL (GRAL) Financials

GRAIL logo
$45.63 -2.81 (-5.80%)
Closing price 04:00 PM Eastern
Extended Trading
$45.44 -0.19 (-0.42%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for GRAIL

Annual Income Statements for GRAIL

This table shows GRAIL's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 1/1/2023 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-5,399 -1,466 -2,027
Consolidated Net Income / (Loss)
-5,399 -1,466 -2,027
Net Income / (Loss) Continuing Operations
-5,399 -1,466 -2,027
Total Pre-Tax Income
-5,441 -1,508 -2,162
Total Operating Income
-5,443 -1,515 -2,189
Total Gross Profit
17 38 56
Total Revenue
56 93 126
Operating Revenue
56 93 126
Total Cost of Revenue
38 55 70
Operating Cost of Revenue
38 55 70
Total Operating Expenses
5,460 1,554 2,245
Selling, General & Admin Expense
174 200 214
Marketing Expense
122 162 154
Research & Development Expense
330 339 322
Amortization Expense
134 134 134
Impairment Charge
4,700 718 1,421
Total Other Income / (Expense), net
1.50 7.75 27
Interest & Investment Income
1.74 7.95 27
Other Income / (Expense), net
-0.24 -0.21 0.06
Income Tax Expense
-42 -42 -135
Basic Earnings per Share
($173.89) ($47.21) ($63.54)
Weighted Average Basic Shares Outstanding
31.05M 31.05M 31.90M
Diluted Earnings per Share
($173.89) ($47.21) ($63.54)
Weighted Average Diluted Shares Outstanding
31.05M 31.05M 31.90M
Weighted Average Basic & Diluted Shares Outstanding
- - 33.90M

Quarterly Income Statements for GRAIL

This table shows GRAIL's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2023 10/1/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-193 -891 -219 -1,585 -126 -106
Consolidated Net Income / (Loss)
-193 -891 -219 -1,585 -126 -106
Net Income / (Loss) Continuing Operations
-193 -891 -219 -1,585 -126 -106
Total Pre-Tax Income
-203 -910 -224 -1,638 -172 -146
Total Operating Income
-204 -912 -227 -1,641 -184 -154
Total Gross Profit
9.19 6.40 12 16 11 14
Total Revenue
22 21 27 32 29 32
Operating Revenue
22 21 27 32 29 32
Total Cost of Revenue
13 14 15 16 17 18
Operating Cost of Revenue
13 14 15 16 17 18
Total Operating Expenses
214 919 239 1,657 195 167
Selling, General & Admin Expense
51 50 57 67 47 45
Marketing Expense
41 37 47 41 36 35
Research & Development Expense
89 80 102 94 78 54
Amortization Expense
33 33 33 33 33 33
Total Other Income / (Expense), net
1.53 2.33 2.94 2.81 11 7.20
Interest & Investment Income
1.85 2.53 2.90 2.81 12 7.78
Other Income / (Expense), net
-0.32 -0.20 0.04 0.01 -0.56 -0.58
Income Tax Expense
-9.80 -19 -5.57 -53 -47 -40
Basic Earnings per Share
($6.22) ($28.71) ($7.05) ($51.06) ($3.94) ($3.10)
Weighted Average Basic Shares Outstanding
31.05M 31.05M 31.05M 31.05M 31.88M 34.31M
Diluted Earnings per Share
($6.22) ($28.71) ($7.05) ($51.06) ($3.94) ($3.10)
Weighted Average Diluted Shares Outstanding
31.05M 31.05M 31.05M 31.05M 31.88M 34.31M
Weighted Average Basic & Diluted Shares Outstanding
- - - 31.05M 33.60M 35.97M

Annual Cash Flow Statements for GRAIL

This table details how cash moves in and out of GRAIL's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 1/1/2023 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
20 -145 116
Net Cash From Operating Activities
-561 -596 -577
Net Cash From Continuing Operating Activities
-561 -596 -577
Net Income / (Loss) Continuing Operations
-5,399 -1,466 -2,027
Consolidated Net Income / (Loss)
-5,399 -1,466 -2,027
Depreciation Expense
16 20 20
Amortization Expense
138 138 135
Non-Cash Adjustments To Reconcile Net Income
4,737 742 1,453
Changes in Operating Assets and Liabilities, net
-54 -30 -159
Net Cash From Investing Activities
-23 -13 -551
Net Cash From Continuing Investing Activities
-23 -13 -551
Purchase of Property, Plant & Equipment
-23 -13 -5.21
Purchase of Investments
0.00 0.00 -546
Net Cash From Financing Activities
605 464 1,244
Net Cash From Continuing Financing Activities
605 464 1,244
Issuance of Common Equity
609 464 1,244
Other Financing Activities, net
-4.18 -0.23 0.00
Effect of Exchange Rate Changes
-0.51 0.31 -0.06

Quarterly Cash Flow Statements for GRAIL

This table details how cash moves in and out of GRAIL's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 10/1/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
-87 -47 102 -106 -640 -80
Net Cash From Operating Activities
-158 -129 -207 -105 -93 -95
Net Cash From Continuing Operating Activities
-158 -129 -207 -105 -93 -95
Net Income / (Loss) Continuing Operations
-891 -188 -219 -126 -97 -106
Consolidated Net Income / (Loss)
-891 -188 -219 -126 -97 -106
Depreciation Expense
5.22 5.35 5.41 4.65 4.86 4.70
Amortization Expense
35 35 35 35 31 28
Non-Cash Adjustments To Reconcile Net Income
705 13 -14 22 11 17
Changes in Operating Assets and Liabilities, net
-11 5.87 -15 -40 -44 -39
Net Cash From Investing Activities
-3.07 -3.90 -2.55 -0.97 -546 15
Net Cash From Continuing Investing Activities
-3.07 -3.90 -2.55 -0.97 -546 15
Purchase of Property, Plant & Equipment
-3.07 -3.90 -2.55 -0.97 -0.30 -0.06
Purchase of Investments
- - 0.00 - - -221
Sale and/or Maturity of Investments
- - 0.00 - - 235
Net Cash From Financing Activities
74 86 312 - - 0.00
Net Cash From Continuing Financing Activities
74 86 312 - - 0.00
Issuance of Common Equity
74 86 312 - - 0.00
Effect of Exchange Rate Changes
- - -0.04 - - 0.06

Annual Balance Sheets for GRAIL

This table presents GRAIL's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Period end date 12/31/2023 12/31/2024
Total Assets
3,914 2,983
Total Current Assets
156 820
Cash & Equivalents
97 214
Short-Term Investments
0.00 549
Accounts Receivable
17 20
Inventories, net
22 19
Prepaid Expenses
20 17
Plant, Property, & Equipment, net
85 69
Total Noncurrent Assets
3,673 2,094
Intangible Assets
2,687 2,017
Other Noncurrent Operating Assets
97 77
Total Liabilities & Shareholders' Equity
3,914 2,983
Total Liabilities
268 480
Total Current Liabilities
164 77
Accounts Payable
20 4.84
Accrued Expenses
74 57
Other Current Liabilities
16 15
Total Noncurrent Liabilities
104 403
Noncurrent Deferred & Payable Income Tax Liabilities
33 346
Other Noncurrent Operating Liabilities
71 57
Total Equity & Noncontrolling Interests
3,646 2,503
Total Preferred & Common Equity
0.00 2,503
Preferred Stock
0.00 0.00
Total Common Equity
3,646 2,503
Common Stock
11,421 12,305
Retained Earnings
-7,776 -9,803
Accumulated Other Comprehensive Income / (Loss)
1.07 1.45

Quarterly Balance Sheets for GRAIL

This table presents GRAIL's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2024 9/30/2024 3/31/2025
Total Assets
3,270 3,118 2,848
Total Current Assets
1,019 910 728
Cash & Equivalents
959 854 134
Short-Term Investments
- - 541
Accounts Receivable
13 15 19
Inventories, net
26 21 19
Prepaid Expenses
21 20 15
Plant, Property, & Equipment, net
78 74 65
Total Noncurrent Assets
2,173 2,134 2,055
Intangible Assets
2,086 2,051 1,982
Other Noncurrent Operating Assets
87 83 73
Total Liabilities & Shareholders' Equity
3,270 3,118 2,848
Total Liabilities
575 530 434
Total Current Liabilities
88 94 75
Accounts Payable
16 7.32 5.77
Accrued Expenses
57 72 54
Other Current Liabilities
15 15 15
Total Noncurrent Liabilities
486 436 359
Noncurrent Deferred & Payable Income Tax Liabilities
422 375 305
Other Noncurrent Operating Liabilities
64 61 54
Total Equity & Noncontrolling Interests
2,695 2,588 2,414
Total Preferred & Common Equity
2,695 2,588 2,414
Preferred Stock
0.00 0.00 0.00
Total Common Equity
2,695 2,588 2,414
Common Stock
12,274 12,292 12,322
Retained Earnings
-9,581 -9,706 -9,910
Accumulated Other Comprehensive Income / (Loss)
1.39 2.19 1.67

Annual Metrics And Ratios for GRAIL

This table displays calculated financial ratios and metrics derived from GRAIL's official financial filings.

Metric 2022 2023 2024
Period end date 1/1/2023 12/31/2023 12/31/2024
Growth Metrics
- - -
Revenue Growth
0.00% 67.61% 34.90%
EBITDA Growth
0.00% 74.34% -49.92%
EBIT Growth
0.00% 72.16% -44.44%
NOPAT Growth
0.00% 72.16% -44.46%
Net Income Growth
0.00% 72.85% -38.30%
EPS Growth
0.00% 72.85% -34.59%
Operating Cash Flow Growth
0.00% -6.14% 3.13%
Free Cash Flow Firm Growth
0.00% 0.00% 106.00%
Invested Capital Growth
0.00% 0.00% -50.97%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00%
Profitability Metrics
- - -
Gross Margin
31.40% 41.11% 44.48%
EBITDA Margin
-9,520.01% -1,457.38% -1,619.65%
Operating Margin
-9,798.18% -1,627.61% -1,743.03%
EBIT Margin
-9,798.61% -1,627.83% -1,742.98%
Profit (Net Income) Margin
-9,719.35% -1,574.23% -1,613.92%
Tax Burden Percent
99.22% 97.22% 93.74%
Interest Burden Percent
99.97% 99.48% 98.78%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -59.78% -57.95%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 772.64% 56.97%
Return on Net Nonoperating Assets (RNNOA)
0.00% -20.62% -7.97%
Return on Equity (ROE)
0.00% -80.40% -65.92%
Cash Return on Invested Capital (CROIC)
0.00% -259.78% 10.46%
Operating Return on Assets (OROA)
0.00% -38.72% -63.48%
Return on Assets (ROA)
0.00% -37.45% -58.78%
Return on Common Equity (ROCE)
0.00% -80.40% -65.92%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% -80.97%
Net Operating Profit after Tax (NOPAT)
-3,810 -1,061 -1,532
NOPAT Margin
-6,858.73% -1,139.32% -1,220.12%
Net Nonoperating Expense Percent (NNEP)
0.00% -832.42% -114.92%
Return On Investment Capital (ROIC_SIMPLE)
- -29.09% -61.21%
Cost of Revenue to Revenue
68.60% 58.89% 55.52%
SG&A Expenses to Revenue
313.43% 215.10% 170.28%
R&D to Revenue
593.30% 363.83% 256.68%
Operating Expenses to Revenue
9,829.58% 1,668.72% 1,787.51%
Earnings before Interest and Taxes (EBIT)
-5,443 -1,516 -2,189
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-5,288 -1,357 -2,034
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 0.00 0.24
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.23
Price to Revenue (P/Rev)
0.00 0.00 4.78
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00
Financial Leverage
0.00 -0.03 -0.14
Leverage Ratio
0.00 1.07 1.12
Compound Leverage Factor
0.00 1.07 1.11
Debt to Total Capital
0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00
Altman Z-Score
0.00 0.00 -5.93
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
0.00 0.95 10.66
Quick Ratio
0.00 0.70 10.19
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -4,610 277
Operating Cash Flow to CapEx
-2,455.54% -4,623.26% -11,082.10%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.00 0.02 0.04
Accounts Receivable Turnover
0.00 5.50 6.74
Inventory Turnover
0.00 2.53 3.46
Fixed Asset Turnover
0.00 1.10 1.63
Accounts Payable Turnover
0.00 2.79 5.69
Days Sales Outstanding (DSO)
0.00 66.42 54.13
Days Inventory Outstanding (DIO)
0.00 144.43 105.55
Days Payable Outstanding (DPO)
0.00 130.97 64.17
Cash Conversion Cycle (CCC)
0.00 79.88 95.51
Capital & Investment Metrics
- - -
Invested Capital
0.00 3,549 1,740
Invested Capital Turnover
0.00 0.05 0.05
Increase / (Decrease) in Invested Capital
0.00 3,549 -1,809
Enterprise Value (EV)
0.00 0.00 -164
Market Capitalization
0.00 0.00 600
Book Value per Share
$0.00 $117.43 $74.50
Tangible Book Value per Share
$0.00 $2.26 $14.48
Total Capital
0.00 3,646 2,503
Total Debt
0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
0.00 -97 -763
Capital Expenditures (CapEx)
23 13 5.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -105 -21
Debt-free Net Working Capital (DFNWC)
0.00 -7.55 743
Net Working Capital (NWC)
0.00 -7.55 743
Net Nonoperating Expense (NNE)
1,589 405 495
Net Nonoperating Obligations (NNO)
0.00 -97 -763
Total Depreciation and Amortization (D&A)
155 159 155
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -112.60% -16.35%
Debt-free Net Working Capital to Revenue
0.00% -8.10% 591.53%
Net Working Capital to Revenue
0.00% -8.10% 591.53%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($63.54)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 31.90M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($63.54)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 31.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 33.90M
Normalized Net Operating Profit after Tax (NOPAT)
-520 -558 -538
Normalized NOPAT Margin
-935.59% -599.15% -428.17%
Pre Tax Income Margin
-9,795.48% -1,619.29% -1,721.69%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for GRAIL

This table displays calculated financial ratios and metrics derived from GRAIL's official financial filings.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2023 10/1/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% 0.00% 42.63% 38.27% 19.15%
EBITDA Growth
0.00% 0.00% 0.00% -839.06% 83.41% 35.27%
EBIT Growth
0.00% 0.00% 0.00% -701.85% 79.83% 32.19%
NOPAT Growth
0.00% 0.00% 0.00% -703.11% 79.89% 32.46%
Net Income Growth
0.00% 0.00% 0.00% -721.23% 85.90% 51.48%
EPS Growth
0.00% 0.00% 0.00% -720.90% 86.28% 56.03%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% 33.60% 54.16%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
0.00% -7.55% 0.00% 0.00% -10.38% 0.00%
EBITDA Q/Q Growth
0.00% -409.76% 0.00% 0.00% 90.99% 0.00%
EBIT Q/Q Growth
0.00% -345.85% 0.00% 0.00% 88.79% 0.00%
NOPAT Q/Q Growth
0.00% -346.45% 0.00% 0.00% 88.82% 0.00%
Net Income Q/Q Growth
0.00% -361.78% 0.00% 0.00% 92.07% 0.00%
EPS Q/Q Growth
0.00% -361.58% 0.00% 0.00% 92.28% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -60.81% 0.00% 0.00% -1.63%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 35.44% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% -0.13% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
41.02% 30.90% 43.27% 48.67% 39.23% 42.54%
EBITDA Margin
-763.88% -4,211.89% -701.26% -5,029.13% -505.51% -380.96%
Operating Margin
-911.78% -4,403.01% -851.10% -5,133.85% -640.47% -482.48%
EBIT Margin
-913.21% -4,403.95% -850.94% -5,133.83% -642.43% -484.31%
Profit (Net Income) Margin
-861.27% -4,301.94% -819.26% -4,958.83% -438.67% -333.62%
Tax Burden Percent
95.17% 97.96% 97.52% 96.76% 72.90% 72.54%
Interest Burden Percent
99.10% 99.72% 98.72% 99.83% 93.66% 94.96%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% -50.77%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% -51.16%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 14.30%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 0.00% -36.47%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% -22.23%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% -15.31%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 0.00% -36.47%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% -79.31%
Net Operating Profit after Tax (NOPAT)
-143 -639 -159 -1,149 -128 -108
NOPAT Margin
-638.25% -3,082.10% -595.77% -3,593.69% -448.33% -337.74%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% -91.03% 0.65% 0.39%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -4.45%
Cost of Revenue to Revenue
58.98% 69.10% 56.73% 51.33% 60.77% 57.46%
SG&A Expenses to Revenue
225.94% 242.17% 213.57% 210.38% 165.50% 141.58%
R&D to Revenue
395.78% 386.43% 380.32% 294.64% 273.04% 168.44%
Operating Expenses to Revenue
952.80% 4,433.91% 894.37% 5,182.52% 679.70% 525.02%
Earnings before Interest and Taxes (EBIT)
-205 -913 -227 -1,641 -184 -154
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-171 -873 -187 -1,608 -145 -121
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.17 0.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.80 2.01
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 6.62
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.11
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 1.46
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 0.00 0.00 -0.36 -0.33 -0.28
Leverage Ratio
0.00 0.00 0.00 1.21 1.20 1.18
Compound Leverage Factor
0.00 0.00 0.00 1.21 1.13 1.12
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 0.00% 0.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 0.00 0.00 0.00 0.00 -3.53
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 0.00 0.00 11.55 9.65 9.71
Quick Ratio
0.00 0.00 0.00 11.03 9.22 9.25
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 -2,885 -1,863 -1,847
Operating Cash Flow to CapEx
0.00% -5,132.32% -8,135.24% 0.00% -10,770.44% -153,245.16%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.05
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 6.77
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 3.89
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 2.02
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 12.63
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 53.92
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 93.75
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 28.90
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 118.77
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 0.00 0.00 1,736 1,734 1,739
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.15
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 1,736 1,734 1,739
Enterprise Value (EV)
0.00 0.00 0.00 0.00 -426 191
Market Capitalization
0.00 0.00 0.00 0.00 427 866
Book Value per Share
$0.00 $0.00 $0.00 $86.80 $83.34 $71.21
Tangible Book Value per Share
$0.00 $0.00 $0.00 $19.62 $17.27 $12.73
Total Capital
0.00 0.00 0.00 2,695 2,588 2,414
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 0.00 0.00 -959 -854 -675
Capital Expenditures (CapEx)
0.00 3.07 2.55 0.00 0.97 0.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 -28 -38 -22
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 931 815 653
Net Working Capital (NWC)
0.00 0.00 0.00 931 815 653
Net Nonoperating Expense (NNE)
50 253 60 436 -2.77 -1.31
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 -959 -854 -675
Total Depreciation and Amortization (D&A)
33 40 40 33 39 33
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% -16.76%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 499.33%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 499.33%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 ($51.06) ($3.94) ($3.10)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 31.05M 31.88M 34.31M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 ($51.06) ($3.94) ($3.10)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 31.05M 31.88M 34.31M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 31.05M 33.60M 35.97M
Normalized Net Operating Profit after Tax (NOPAT)
-143 -136 -159 -154 -128 -108
Normalized NOPAT Margin
-638.25% -655.09% -595.77% -482.48% -448.33% -337.74%
Pre Tax Income Margin
-904.97% -4,391.75% -840.08% -5,125.06% -601.73% -459.88%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Key Financial Trends

GRAIL reported Q1 2025 operating revenue of $31.8 million, up 19.1% year-over-year, reflecting growing adoption of its early cancer detection assays. Profitability metrics improved modestly, though the company remains unprofitable and continues to invest heavily in R&D and marketing. The balance sheet shows a strong net cash position, but cash burn remains significant.

  • Year-over-year revenue growth of 19.1% in Q1 2025, driven by expanding test volumes.
  • EBITDA improved by 35.3% year-over-year, with EBITDA margin narrowing from -5.06% (Q1 2024) to -3.81%.
  • NOPAT margin improved from -5.96% in Q1 2024 to -3.38% in Q1 2025, indicating better operating efficiency.
  • Net cash position remains strong with net debt of -$674.6 million, reflecting no debt on the balance sheet.
  • High liquidity preserved: current ratio of 9.7x and quick ratio of 9.25x as of Q1 2025.
  • Operating cash flow was negative $95 million in Q1 2025, though improved from -$207 million a year ago.
  • SG&A and R&D expenses remain elevated at 141.6% and 168.4% of revenue, respectively, underscoring heavy investment for future growth.
  • Free cash flow to the firm remains deeply negative at -$1.85 billion, driven by working capital and net non-operating obligations.
  • Net loss of $106.2 million in Q1 2025, continuing the trend of quarterly losses.
  • Altman Z-Score of -3.53 and negative ROIC (-50.8%) highlight ongoing operating challenges and financial risk.
06/20/25 03:23 PMAI Generated. May Contain Errors.

Frequently Asked Questions About GRAIL's Financials

When does GRAIL's fiscal year end?

According to the most recent income statement we have on file, GRAIL's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has GRAIL's net income changed over the last 2 years?

GRAIL's net income appears to be on a downward trend, with a most recent value of -$2.03 billion in 2024, falling from -$5.40 billion in 2022. The previous period was -$1.47 billion in 2023. See GRAIL's forecast for analyst expectations on what’s next for the company.

What is GRAIL's operating income?
GRAIL's total operating income in 2024 was -$2.19 billion, based on the following breakdown:
  • Total Gross Profit: $55.87 million
  • Total Operating Expenses: $2.25 billion
How has GRAIL's revenue changed over the last 2 years?

Over the last 2 years, GRAIL's total revenue changed from $55.55 million in 2022 to $125.60 million in 2024, a change of 126.1%.

How much debt does GRAIL have?

GRAIL's total liabilities were at $479.90 million at the end of 2024, a 79.3% increase from 2023, and a 79.3% increase since 2023.

How much cash does GRAIL have?

In the past 1 years, GRAIL's cash and equivalents has ranged from $97.29 million in 2023 to $214.23 million in 2024, and is currently $214.23 million as of their latest financial filing in 2024.

How has GRAIL's book value per share changed over the last 2 years?

Over the last 2 years, GRAIL's book value per share changed from 0.00 in 2022 to 74.50 in 2024, a change of 7,450.4%.



This page (NASDAQ:GRAL) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners